Evidence map›Paper›PMID 29946440›Full record

ArticleF1000Research2018

segment_liftover : a Python tool to convert segments between genome assemblies.

Bo Gao, Qingyao Huang, Michael Baudis

Abstract read
In one paragraph

Article in F1000Research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. The Progenetix oncogenomic resource in 2021.Database : the journal of biological databases and curation · 2021
    Pooled it
  2. Article
  3. Article
  4. cancercelllines.org-a novel resource for genomic variants in cancer cell lines.Database : the journal of biological databases and curation · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. RBP EIF2S2 Promotes Tumorigenesis and Progression by Regulating MYC-Mediated Inhibition via FHIT-Related Enhancers.Molecular therapy : the journal of the American Society of Gene Therapy · 2020
    Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Bo GaoInstitute of molecular Life Sciences, University of Zürich, Zürich, CH-8057, Switzerland.ORCID https://orcid.org/0000-0003-2818-4000
Qingyao HuangInstitute of molecular Life Sciences, University of Zürich, Zürich, CH-8057, Switzerland.
Michael BaudisInstitute of molecular Life Sciences, University of Zürich, Zürich, CH-8057, Switzerland.ORCID https://orcid.org/0000-0002-9903-4248

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The process of assembling a species' reference genome may be performed in a number of iterations, with subsequent genome assemblies differing in the coordinates of mapped elements. The conversion of genome coordinates between different assemblies is required for many integrative and comparative studies. While currently a number of bioinformatics tools are available to accomplish this task, most of them are tailored towards the conversion of single genome coordinates. When converting the boundary positions of segments spanning larger genome regions, segments may be mapped into smaller sub-segments if the original segment's continuity is disrupted in the target assembly. Such a conversion may lead to a relevant degree of data loss in some circumstances such as copy number variation (CNV) analysis, where the quantitative representation of a genomic region takes precedence over base-specific accuracy.

Indexed as

copy number segment.Genome assemblyliftoverremap

Identifiers

PMID29946440
PMCPMC5998006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.